Annemarie C. de Vries
Erasmus MC(NL)
Publications by Year
Research Areas
Inflammatory Bowel Disease, Microscopic Colitis, Eosinophilic Esophagitis, Helicobacter pylori-related gastroenterology studies, Autoimmune and Inflammatory Disorders
Most-Cited Works
- → Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn’s disease patients with prior failure to anti‐TNF treatment(2020)126 cited
- → Randomized Controlled Trials of Antibiotic Prophylaxis in Severe Acute Pancreatitis: Relationship between Methodological Quality and Outcome(2007)110 cited
- → Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases(2019)97 cited
- → Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry(2020)85 cited
- → Decreasing Trends in Intestinal Resection and Re-Resection in Crohn's Disease(2019)45 cited
- → High Immunogenicity to Influenza Vaccination in Crohn’s Disease Patients Treated with Ustekinumab(2020)45 cited
- → Risk Prediction and Comparative Efficacy of Anti-TNF vs Thiopurines, for Preventing Postoperative Recurrence in Crohn's Disease: A Pooled Analysis of 6 Trials(2021)40 cited
- → Ustekinuma b for Crohn’s Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, a Nationwide Prospective Observational Cohort Study(2021)40 cited
- → Prediction of Relapse After Anti–Tumor Necrosis Factor Cessation in Crohn’s Disease: Individual Participant Data Meta-analysis of 1317 Patients From 14 Studies(2021)39 cited
- → Non-stem cell lineages as an alternative origin of intestinal tumorigenesis in the context of inflammation(2024)38 cited